Premium Nahrungsergänzungsmittel | artgerecht

Eplerenone – Effects, Dosage and Side Effects

Eplerenone is a prescription medication belonging to the class of aldosterone antagonists, used in the treatment of heart failure and high blood pressure.

Regular tips about health Regular tips about health

Things worth knowing about "Eplerenone"

Eplerenone is a prescription medication belonging to the class of aldosterone antagonists, used in the treatment of heart failure and high blood pressure.

What is Eplerenone?

Eplerenone is a selective aldosterone antagonist classified as a potassium-sparing diuretic. It works by blocking the mineralocorticoid receptor, thereby preventing the hormone aldosterone from exerting its effects in the body. Eplerenone is available as a prescription-only medicine and is approved in Europe and the United States under various brand names.

Indications

Eplerenone is used in the following conditions:

Heart failure following a myocardial infarction (heart attack) – to reduce the risk of death in patients with reduced left ventricular function
Chronic heart failure with reduced ejection fraction (HFrEF) as part of a comprehensive treatment regimen
Essential hypertension (high blood pressure), particularly when other treatments are insufficient

Mechanism of Action

Aldosterone is a hormone produced by the adrenal cortex that promotes sodium and water retention in the kidneys while causing potassium excretion. Excess aldosterone can contribute to high blood pressure, cardiac fibrosis, and ventricular hypertrophy (thickening of the heart muscle).

Eplerenone selectively binds to the mineralocorticoid receptor and blocks its activation by aldosterone. Compared to the older drug spironolactone, eplerenone has a higher selectivity for this receptor and has minimal affinity for androgen or progesterone receptors. This significantly reduces hormone-related side effects such as gynecomastia (breast tissue growth in men).

Blocking the mineralocorticoid receptor results in:

Reduced sodium and water reabsorption in the kidneys
Increased potassium retention (potassium-sparing effect)
Lowering of blood pressure
Protection of the heart muscle against fibrotic remodeling (cardioprotection)

Dosage

The dosage of eplerenone depends on the indication and the patient's kidney function:

Post-myocardial infarction / Heart failure: Treatment is typically started at 25 mg once daily, increasing to 50 mg once daily after 4 weeks, provided serum potassium levels allow.
Hypertension: Standard starting dose is 50 mg once daily, which may be increased to 50 mg twice daily if needed.

Eplerenone is taken as a tablet and can be taken with or without food. The exact dose is determined by the treating physician.

Side Effects

Eplerenone is generally well tolerated. Possible side effects include:

Hyperkalemia (elevated potassium levels in the blood) – especially in patients with reduced kidney function or those taking other potassium-raising agents
Dizziness and headache
Elevated creatinine and urea levels (indicating changes in kidney function)
Fatigue and weakness
Rarely: gynecomastia (much less common than with spironolactone)

Regular monitoring of potassium levels and kidney function is essential during treatment with eplerenone.

Contraindications

Eplerenone must not be used in patients with:

Pre-existing hyperkalemia (elevated blood potassium)
Severe renal insufficiency
Concomitant use of strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole)
Concomitant use of other potassium-sparing diuretics or potassium supplements

Drug Interactions

Eplerenone is metabolized in the liver by the enzyme CYP3A4. Medications that inhibit or induce this enzyme can increase or decrease the effects of eplerenone. Particular caution is required with:

ACE inhibitors and angiotensin receptor blockers (increased risk of hyperkalemia)
Non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen
Lithium (risk of increased lithium toxicity)

Important Notes on Use

Eplerenone is a prescription-only medication and must only be taken under medical supervision. Regular blood tests (potassium levels, kidney function) are essential to detect potential adverse effects early. Patients should inform their doctor about all other medications, dietary supplements, and existing medical conditions.

References

European Medicines Agency (EMA): Eplerenone – Product Information and Assessment Report. www.ema.europa.eu
Pitt B et al. – Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. New England Journal of Medicine, 2003; 348(14):1309–1321.
Zannad F et al. – Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms (EMPHASIS-HF). New England Journal of Medicine, 2011; 364(1):11–21.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.